Magic mushroom therapy tested for untreatable cancer pain
NCT ID NCT06001749
Summary
This study is testing whether psilocybin, the active compound in 'magic mushrooms,' combined with therapy can help reduce severe pain in people with advanced cancer when standard opioid painkillers are not effective enough. About 15 participants will receive one dose of psilocybin in a controlled therapy session and be followed for 12 weeks to see if their pain and its impact on daily life improves. The main goal is to see if this approach is safe, practical, and acceptable to patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.